Skip to content

The correlation between a severity of lower urinary tract symptoms and adipocytokines concentrations

The correlation between a severity of lower urinary tract symptoms and adipocytokines concentrations - The correlation between a severity of lower urinary tract symptoms and adipocytokines concentrations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033750
Enrollment
250
Registered
2018-11-01
Start date
2018-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patinets with lower urinary tract symptoms, including benign prostatic hyperplasia and overactive bladder

Interventions

None listed

Sponsors

Nagoya University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients who visited our hospital with a chief complaint of lower urinary tract symptoms

Exclusion criteria

Exclusion criteria: Medical conditions for exclusion were neurogenic bladder dysfunction, bladder calculi, active urinary tract infection, severe cardiac disease, renal dysfunction (serum creatinine level more than 5 mg/dL), and/or hepatic dysfunction (Child-Pugh level more than 10 points).

Design outcomes

Primary

MeasureTime frame
the correlation between a severity of lower urinary tract symptoms and adipocytokines concentrations

Countries

Japan

Contacts

Public ContactYoshihisa Matsukawa

Nagoya University Graduate School of Medicine Department of Urology

yoshi44@med.nagoya-u.ac.jp052-744-2985

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026